IIQ 2.65% 58.0¢ inoviq ltd

Ann: Appendix 4E and Annual Report to Shareholders, page-20

  1. 366 Posts.
    lightbulb Created with Sketch. 102
    @Davyboy - working on a similar project to the one discussed, not that easy to sell a test unless it has been clinically validated and rubber stamped by the relevant regulatory bodies, we are sponsored by massive American multinational and it has taken 6 years to get it to market for launch in three months. Its hard going regardless of how much money you have backing you- granted it makes some steps easier but usually not quicker. I understand your frustration at the recent SP direction and the cash flow position but i think that that we will have further clarity by the end of the year, the main deficit at the moment is the communication or lack of...stay well
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.